FAQs & How to use this site
Home | About Us | Contact Us

        Members Patients Visitors Media        

Welcome to the SWOG website

SWOG is a worldwide network of researchers that design and conduct cancer clinical trials. The group's goal is to change medical practice so it improves the lives of people with cancer. SWOG trials test new ways to diagnose and treat cancer, as well as prevent it. SWOG researchers also study ways to improve the care cancer patients receive, and improve quality of life for both patients and survivors.

National Clinical Trials Network

SWOG has been awarded a grant by the National Cancer Institute (NCI) as a member of the NCI National Clinical Trials Network (NCTN).

SWOG has also been awarded a grant by the NCI as a member of the National Cancer Institute Community Oncology Program (NCORP).

If you are not a member of SWOG, check out our Visitors pages, which contain information about our history and leadership, how to join our group, our clinical trials, the published results of those trials, and other information.

New Colorectal Cancer Targeted Therapy Combination Shows Promise
SWOG investigator Dr. Scott Kopetz and his team present study findings at ASCO's 2017 Gastrointestinal Cancers Symposium that show significantly better outcomes for metastatic colorectal cancer patients using a new targeted therapy combination.
 Visit this page
  SWOG Launches Immunotherapy Trial for Rare Cancers
People with rare cancers now have the option of joining a clinical trial testing leading-edge immunotherapies for a wide variety of tumor types. Itís the first federally funded immunotherapy trial devoted to rare cancers.
 Visit this page
Our Inaugural Impact Report
View our progress in 2106 with SWOG's first annual impact report, a collection of our most important data and highlights.
 Visit this page
  Triple Chemo Combination Promising for Myeloma
A SWOG trial shows that the addition of bortezomib to the standard chemotherapy treatment for myeloma delays recurrence and lengthens life, indicating a possible new standard of care. Results are published in The Lancet.
 Visit this page

The Hope Foundation supports the Group's work.
SWOG members may log on here at either the Standard Level (formerly called Level 2) or Advanced Level (formerly called Level 1).
Explanation, Help, and Options

Links to featured sections

 About SWOG

 Staff Directory

 The Front Line

 Group Meeting

 Translational Medicine

 Patient Reported Outcome Training

 SWOG Employment Page

SWOG Logo Disclaimer | Copyright ©2000-2017 SWOG. All rights reserved.
Design by nuMedia Group Inc. | Hosting by WorldPost Technologies, Inc.
SWOG is FISMA CertifiedSWOG is FISMA Certified